Analysis reveals pulmonary vein stenosis impacts mortality and healthcare costs in preterm infants, indicating a need for better surveillance.
Background Pulmonary vein stenosis (PVS) is increasingly recognized in preterm infants, yet data regarding characteristics and outcomes remain limited. Methods A review of hospitalizations from 50 children’s hospitals across the United States participating in the Pediatric Health Information System (PHIS) database was performed. We identified 268,461 pediatric patients (≤24 months of age) with a history of prematurity (<37 weeks’ gestation) admitted between 2016 and 2024. PVS was identified in 703 (0.3%) using ICD-10 diagnosis code I28.8. Results Bronchopulmonary dysplasia, birthweight ≤1.5 kg, Oxygen and ventilator dependency at discharge, pulmonary hypertension, left-to-right shunt lesions, and necrotizing enterocolitis were associated with PVS. Interestingly, gestational age <28 weeks was not associated with PVS. Patients with PVS had higher in-hospital mortality (11.4% vs 2%, p < 0.01), longer hospitalization, and substantially higher adjusted hospitalization costs. After adjusting for prematurity and comorbidities, PVS remained associated with in-hospital mortality (OR 4.3, 95% CI 3.4–5.5, p < 0.01). Conclusion PVS in preterm infants is associated with in-hospital mortality, morbidity, and resource utilization, highlighting the need for improved recognition and structured surveillance
No takes yet. Share an insight, caveat, or question.
Elsisy et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: